نتایج جستجو برای: pca diagnosis

تعداد نتایج: 489498  

Journal: :European urology 2009
Hendrik Isbarn Jehonathan H Pinthus Leonard S Marks Francesco Montorsi Alvaro Morales Abraham Morgentaler Claude Schulman

CONTEXT Androgens are vital for growth and maintenance of the prostate; however, the notion that pathologic prostate growth, benign or malignant, can be stimulated by androgens is a commonly held belief without scientific basis. Therefore, the current prostatic guidelines for testosterone therapy (TT) appear to be overly restrictive and should be reexamined. OBJECTIVE To review the literature...

2013
Ranlu Liu Xiaoqiang Xie Zhihong Zhang Yong Xu

BACKGROUND Prostate cancer (PCa) originating from the prostate base may intrude into the urinary bladder and may be misdiagnosed as bladder cancer. In this retrospective study, we reviewed the clinic data on PCa cases which were initially misdiagnosed as bladder cancer in order to identify diagnostic methods that would allow a better differential diagnosis for PCa. METHODS Out of a total of 4...

Journal: :The Journal of clinical investigation 2009
Simona Nanni Valentina Benvenuti Annalisa Grasselli Carmen Priolo Aurora Aiello Stefania Mattiussi Claudia Colussi Vittoria Lirangi Barbara Illi Manuela D'Eletto Anna Maria Cianciulli Michele Gallucci Piero De Carli Steno Sentinelli Marcella Mottolese Paolo Carlini Lidia Strigari Stephen Finn Elke Mueller Giorgio Arcangeli Carlo Gaetano Maurizio C Capogrossi Raffaele Perrone Donnorso Silvia Bacchetti Ada Sacchi Alfredo Pontecorvi Massimo Loda Antonella Farsetti

The identification of biomarkers that distinguish between aggressive and indolent forms of prostate cancer (PCa) is crucial for diagnosis and treatment. In this study, we used cultured cells derived from prostate tissue from patients with PCa to define a molecular mechanism underlying the most aggressive form of PCa that involves the functional activation of eNOS and HIFs in association with es...

2013
Marina Rigau Mireia Olivan Marta Garcia Tamara Sequeiros Melania Montes Eva Colás Marta Llauradó Jacques Planas Inés de Torres Juan Morote Colin Cooper Jaume Reventós Jeremy Clark Andreas Doll

In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who should avoid over-treatment. Current screening techniques lack specificity, and a decisive diagnosis ...

2012
Siebren Dijkstra Agus Rizal A. H. Hamid Gisèle H. J. M. Leyten Jack A. Schalken

Current criteria to predict low-risk prostate cancer (PCa) are still subject to discussion as a substantial number of PCa patients who progress to a more aggressive disease seem to be missed, using these criteria. The main challenge in PCa diagnosis, therefore, is to distinguish patients with low-risk PCa who will show slow progression of disease from patients at risk for progression to a more ...

Journal: :Frontiers in bioscience 2017
Gati Krushna Panigrahi Gagan Deep

African American men in the United States have higher incidence and mortality rates due to prostate cancer (PCa) compared to other races. In 2016 alone, nearly 30,000 cases of PCa in African American men were diagnosed and 4,450 men died from PCa. The underlying reasons for this health disparity in PCa are complex and include social, economic, and biologic determinants. To reduce or eliminate t...

Journal: :Anticancer research 2015
Thiago B Silva Cleyton Z Oliveira Eliney F Faria Edmundo C Mauad Kari J Syrjänen André L Carvalho

AIM To develop and validate a nomogram to estimate the probability of prostate cancer (PCa) in men undergoing opportunistic screening. PATIENTS AND METHODS This was a cross-sectional observational study on a cohort of men screened for PCa at the Barretos Cancer Hospital (BCH) between January 2004 and December 2007. Patients' data were collected from their charts and binary logistic regression...

2016
Belinda Nghiem Xiaotun Zhang Hung-Ming Lam Lawrence D. True Ilsa Coleman Celestia S. Higano Peter S. Nelson Colin C. Pritchard Colm Morrissey

Objective Although the utility of immunohistochemistry (IHC) for assessing mismatch repair (MMR) protein expression has been demonstrated in solid tumors including primary prostate cancer (PCa), its utility has not been assessed in castration-resistant PCa (CRPC). Methods Tissue microarrays were constructed from 127 radical prostatectomies and 155 CRPC metastases from 50 patients. MMR (MLH1, ...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2013
Na-Na Wang Yong Xu Kuo Yang Dong Wei Yao-Guang Zhang Ming Liu Xiao-Hong Shi Si-Ying Liang Liang Sun Xiao-Quan Zhu Yi-Ge Yang Lei Tang Cheng-Xiao Zhao Xin Wang Xin Chen Juan Hui Yu-Hong Zhang Ling Zhu Fan Yang Yu-Rong Zhang Ze Yang Jian-Ye Wang

BACKGROUND KLK3 gene products, like human prostate-specific antigen (PSA), are important biomarkers in the clinical diagnosis of prostate cancer (PCa). G protein-coupled receptor RFX6, C2orf43 and FOXP4 signaling plays important roles in the development of PCa. However, associations of these genes with PCa in northern Chinese men remain to be detailed. This study aimed to investigate their impa...

2016
Momir Polenakovic Katarina Davalieva

The use of prostate specific antigen (PSA)-based screening of prostate cancer (PCa) results with overdiagnosis of the disease, unnecessary biopsies and high medical cost treatments. The discovery of new biomarkers in blood, urine or tissue that will permit early detection and treatment of patients with aggressive disease and, concomitantly, avoid overtreatment for low risk cases are urgently ne...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید